Back

Medscape, LLC

  • Antibodies, Bispecific

Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case Based Discussion

The goal of this activity is for learners to be better able to incorporate bispecific antibodies into clinical practice and individualize care for R/R DLBCL.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.25 creditsNursingUp to 1.25 creditsPharmacyUp to 1.25 credits

MOC types

ABIM — Medical KnowledgeUp to 1.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.25 credits
  • MOC · Up to 1.25 points
  • Commercial Support
  • Released
    Dec 18, 2025
  • Last day to claim credit
    Dec 19, 2026 2 months left